The global liver cancer therapeutics market, valued at US$3.36 billion in 2024, is projected to reach US$13.16 billion by 2033 at a 16.5% CAGR. Explore drivers like rising HCC cases (800K+ annually worldwide), hepatitis B/C prevalence, and innovations in immunotherapy (Imfinzi + Imjudo) amid targeted TKIs and NAFLD surges. https://finance.yahoo.com/news/liver-cancer-therapeutics-market-size-140100776.html